Mobile

A randomised, single-dose, dose ascending, double-blind, placebo controlled, four-way, incomplete block crossover study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics o...

Mise à jour : Il y a 5 ans
Référence : EUCTR2007-001391-37

A randomised, single-dose, dose ascending, double-blind, placebo controlled, four-way, incomplete block crossover study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of inhaled doses of GW642444M with magnesium stearate in COPD patients

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the safety and tolerability of single doses of GW642444M with magnesium stearate (25, 50 and 100 mcg) in COPD patients

Critère d'inclusion

  • COPD patients (moderate)

Liens